Cam Newton changed his mind about the New England Patriots. The former Patriots quarterback caused a stir by calling New England’s hot streak “fool’s gold” on ESPN last month. Newton framed the ...

The Pittsburgh Penguins are a simple story. It’s not a very good roster. Evgeni Malkin getting hurt triggered the Penguins losing eight straight. But Malkin’s absence wasn’t responsible for their four ...

Adam Spatacco is a contributing Motley Fool technology analyst covering artificial intelligence, robotics, autonomous driving, e-commerce, and cybersecurity stocks. Previously, Adam was an investment ...

A Fool since 2019, and a graduate of Cal State LA with a B.S. in Finance and M.A. in Economics. Parkev is an adjunct professor of Finance and enjoys reading about financial and economic history.

For decades, the Food and Drug Administration was the undisputed global gold standard for regulation. While other nations might approve drugs faster or cheaper, an FDA approval was special. It was a ...

About the author: Cullen S. Hendrix is a senior fellow at the Peterson Institute for International Economics. He has consulted for the World Food Programme, USAID, the World Bank, and the U.S.